StockData
Harrow, Inc. logo

Harrow, Inc. (HROW) stock

HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$29.52+0.43 (+1.48%)

Close on Nov 17, 2026Market cap $1.11BP/E –Yield –

Harrow price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Harrow's price to sales ratio was 4.0× on Nov 11, 2026, against 6.2× a year earlier. Over the last 5 years it ranged from 2.3× to 10.4×, with a median of 4.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20264.0×−3.3
2025Dec 31, 20257.3×+0.2
2024Dec 31, 20247.1×+3.6
2023Dec 29, 20233.4×−1.1
2022Dec 30, 20224.5×+1.0
2021Dec 31, 20213.5×−0.3
2020Dec 31, 20203.8×−0.2
2019Dec 31, 20193.9×+0.5
2018Dec 31, 20183.5×+2.1
2017Dec 29, 20171.4×−0.5
2016Dec 30, 20161.9×−8.0
2015Dec 31, 20159.9×−52.4
2014Dec 31, 201462.3×–

More Harrow figures

See a number that looks wrong?